You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Moodys
Mallinckrodt
Merck
Harvard Business School

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Drug Sales Trends for ZYCLARA

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for ZYCLARA (2018)

Revenues by Pharmacy Type

Pharmacy Type Revenues
$25,276,108
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
18,267
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICARE $20,298,228
PRIVATE INSURANCE $6,020,024
[disabled in preview] $5,203,565
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ZYCLARA
Drug Units Sold Trends for ZYCLARA

Annual Sales Revenues and Units Sold for ZYCLARA

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
ZYCLARA   Start Trial   Start Trial 2018
ZYCLARA   Start Trial   Start Trial 2017
ZYCLARA   Start Trial   Start Trial 2016
ZYCLARA   Start Trial   Start Trial 2015
ZYCLARA   Start Trial   Start Trial 2014
ZYCLARA   Start Trial   Start Trial 2013
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Express Scripts
Baxter
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.